These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25976869)

  • 1. Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.
    Zee J; Xie SX;
    Clin Trials; 2015 Aug; 12(4):333-41. PubMed ID: 25976869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.
    Zee J; Xie SX
    Biometrics; 2015 Sep; 71(3):772-81. PubMed ID: 25916510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of covariate-specific time-dependent ROC curves in the presence of missing biomarkers.
    Li S; Ning Y
    Biometrics; 2015 Sep; 71(3):666-76. PubMed ID: 25891918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.
    Sertdemir Y; Burgut R
    Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric analysis of incomplete current status outcome data under transformation models.
    Wen CC; Chen YH
    Biometrics; 2014 Jun; 70(2):335-45. PubMed ID: 24571634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric transformation models for semicompeting survival data.
    Lin H; Zhou L; Li C; Li Y
    Biometrics; 2014 Sep; 70(3):599-607. PubMed ID: 24749525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A profile conditional likelihood approach for the semiparametric transformation regression model with missing covariates.
    Chen HY; Little RJ
    Lifetime Data Anal; 2001 Sep; 7(3):207-24. PubMed ID: 11677827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric approaches for joint modeling of longitudinal and survival data with time-varying coefficients.
    Song X; Wang CY
    Biometrics; 2008 Jun; 64(2):557-66. PubMed ID: 17725812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure.
    Lu K; Tsiatis AA
    Lifetime Data Anal; 2005 Mar; 11(1):29-40. PubMed ID: 15747588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the value of a censored surrogate outcome.
    Parast L; Tian L; Cai T
    Lifetime Data Anal; 2020 Apr; 26(2):245-265. PubMed ID: 30980316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time.
    Baker SG; Sargent DJ; Buyse M; Burzykowski T
    Biometrics; 2012 Mar; 68(1):248-57. PubMed ID: 21838732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of linear transformation models with covariate measurement error and interval censoring.
    Mandal S; Wang S; Sinha S
    Stat Med; 2019 Oct; 38(23):4642-4655. PubMed ID: 31347177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches.
    Lassere M; Johnson K; Hughes M; Altman D; Buyse M; Galbraith S; Wells G
    J Rheumatol; 2007 Mar; 34(3):616-9. PubMed ID: 17343308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric temporal process regression of survival-out-of-hospital.
    Zhan T; Schaubel DE
    Lifetime Data Anal; 2019 Apr; 25(2):322-340. PubMed ID: 29796979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive hazards model with auxiliary subgroup survival information.
    He J; Li H; Zhang S; Duan X
    Lifetime Data Anal; 2019 Jan; 25(1):128-149. PubMed ID: 29470696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiparametric methods in the proportional odds model for ordinal response data with missing covariates.
    Lee SM; Gee MJ; Hsieh SH
    Biometrics; 2011 Sep; 67(3):788-98. PubMed ID: 21039396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple test for independent censoring under the proportional hazards model.
    Lee SY; Wolfe RA
    Biometrics; 1998 Sep; 54(3):1176-82. PubMed ID: 9840972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.